𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P114. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma – Correlation with histologic differentiation

✍ Scribed by P.V. Angadi

Book ID
113833899
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
38 KB
Volume
47
Category
Article
ISSN
1368-8375

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53, Rb, and cyclin D1 expression in hum
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas
✍ Irma B. Gimenez-Conti; Ana M. Collet; Hector Lanfranchi; Maria E. Itoiz; Mario L 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB

## Background: The verrucous carcinoma (vc), a tumor with low grade malignancy, appears to be associated with tobacco and human papillomavirus. the pathobiology of these tumors has not been extensively studied, and molecular genetic alterations have not been reported. in this study we investigated

Cyclin D1 overexpression associates with
Cyclin D1 overexpression associates with radiosensitivity in oral squamous cell carcinoma
✍ Satoru Shintani; Mariko Mihara; Yoshiya Ueyama; Tomohiro Matsumura; David T.W. W 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 344 KB 👁 1 views

## Abstract Overexpression of cyclin D1, a G1 cell cycle regulator, is often found in many different tumor types, including oral squamous cell carcinomas (SCC). Recent laboratory experiments have demonstrated that cyclin D1 levels can influence radiosensitivity in various cell lines. This study eva

Inhibition of cyclin D1 expression by cy
Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity
✍ Xiaojian Zhou; Zhiyuan Zhang; Xiao Yang; Wantao Chen; Ping Zhang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 431 KB 👁 2 views

## Abstract Cyclin D1 is a well‐known cell cycle regulator. Recently, its pro‐survival function has been revealed in several tumors. Because increasing expression of cyclin D1 is a common event in oral squamous cell carcinoma (OSCC) and has been correlated with cisplatin resistance, we investigated